Search Results 1231-1240 of 13923 for Assay

1. Curriculum - Cardiology, Genomics Fellowship (Minnesota) - Mayo Clinic College of Medicine & Science

   Variant Curation: Opportunity to participate in ClinGen's Variant Curation Expert Panels and develop functional assays to assess variant pathogenicity. Rare ...

2. A Study To Evaluate If New Tests (“biomarkers”) Of Blood, Stool, Pancreas Cyst Fluid, Or Pancreas Juice Can Be Used To Diagnose Malignant Or Pre-malignant Changes In People With Pancreas Cysts - Mayo Clinic

   A Study To Evaluate If New Tests (“biomarkers”) Of Blood, Stool, Pancreas Cyst Fluid, Or Pancreas Juice Can Be Used To Diagnose Malignant Or Pre-malignant ...

3. Study Of Imprime PGG And Pembrolizumab In Advanced Melanoma And Triple Negative Breast Cancer - Mayo Clinic

   TNBC is defined as negative immunohistochemistry (IHC) assays for Estrogen Receptor (ER), and Progesterone Receptor (PR), and HER2 negative (IHC 0 or 1+, or 2+ ...

4. A Study to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors - Mayo Clinic

   Participants who are HCV antibody positive will be screened for HCV RNA by any RT PCR or bDNA assay. If HCV antibody is positive, eligibility will be ...

5. A Phase 1b/2 Study of Onvansertib (PCM-075) in Combination with FOLFIRI and Bevacizumab for Second-Line Treatment of Metastatic Colorectal Cancer in Patients with a KRAS Mutation - Mayo Clinic

   ... assays. Submission of the tissue does not have to occur prior to enrollment. Signed informed consent to provide blood sample(s) for specific correlative assays.

6. SPECT Scan Clinical Trials - Mayo Clinic Research

   As a secondary (exploratory) objective, we seek to establish and validate novel biomarker assays to screen for TTR-CA using blood and urine samples ...

7. A Phase 1 Dose Escalation And Cohort Expansion Study Of TSR-042, An Anti-PD-1 Monoclonal Antibody, In Patients With Advanced Solid Tumors - Mayo Clinic

   ... assays and in vivo animal models. Kumar S. Sujatha; Ghosh S. Srimoyee; Sharma G. Geeta; Wang Z. Zebin; Kehry MR. Marilyn R; Marino MH. Margaret H; Neben TY ...

8. A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients - Mayo Clinic

   evidence of such abuse as indicated by the laboratory assays conducted during screening. 16. The Investigator should be guided by the following criteria ...

9. A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM) - Mayo Clinic

   release assay (IGRA) test at screening, unless documented history of appropriate treatment for active or latent TB according to local guidelines. 10. Any ...

10. Surendra Dasari, Ph.D. - Mayo Clinic Faculty Profiles

    The same platform is being applied to develop cancer subtyping assays. The novel biomarkers resulting from his cancer proteogenomics research will be ...